A Study of BN104 in the Treatment of Acute Leukemia

Clinical trial NCT06052813 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06052813
Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ALL, Adult AML, Adult Acute Leukaemia KMT2A Rearrangement NPM1 Mutation NUP98 Gene Rearrangement Menin Inhibitors

Start date: 2023-10-19
Primary completion: 2026-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.